Drugs / 1,4 diaminobutane
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03376620 Comparator | Sep 2011 → Aug 2013 | reactive cutaneous fibrous lesion | University of Manitoba | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1,4 diaminobutane | “The active molecule is called Fibrostat or 1,4 diaminobutane and is a naturally occurring inhibitor of scar formation.” NCT03376620 ↗ |
| Known as | Fibrostat | “The active molecule is called Fibrostat or 1,4 diaminobutane and is a naturally occurring inhibitor of scar formation.” NCT03376620 ↗ |
| Action | Inhibit | “Objective evidence for the role of inhibition of collagen cross-linking in human scar using a nontoxic topical inhibitor, 1,4-diaminobutane (1,4 DAB), in patients with scars at...” PMID 31881614 ↗ Jan 2020 |
| Route | Topical | “Other breast scar treated daily with active cream with 1,4 diaminobutane topically OD at hs” NCT03376620 ↗ |